Literature DB >> 1184727

Thyrotropin and prolactin pituitary reserve in the "empty sella syndrome".

E C Ridgway, I A Kourides, B Kliman, T Bigos, F Maloof.   

Abstract

Ten patients (8 women, 2 men) with the "empty sella syndrome" were studied to evaluate the pituitary reserve of human thyrotropin (hTSH) and prolactin (hPRL). None of the patients had signs or symptoms of hypopituitarism or primary hypothyroidism. All patients had normal baseline thyroid function tests except for 2 patients with mild elevations in total triiodothyronine as measured by competitive protein displacement assay (T3D). Eight of ten patients had normal hTSH responses to thyrotropin releasing hormone (TRH), whereas the 2 patients with elevated T3D had blunted TRH responses. In the 4 patients studied, the metabolic clearance (MCR) and production rates (PR) of hTSH were normal. In 9 of 10 patients normal baseline serum hPRL levels were detected, and each responded to TRH. In one case serum hPRL was undetectable and failed to respond to TRH. The assessment of other anterior pituitary function revealed few minor abnormalities. In summary, like other anterior pituitary hormones, the pituitary reserve in "empty sella syndrome" of hTSH and hPRL is usually normal. When abnormalities do occur, they are attributable to other co-existent endocrine pathology.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1184727     DOI: 10.1210/jcem-41-5-968

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Growth hormone insufficiency in a girl with the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  A Franzese; G Valerio; S Di Maio; M P Iannucci; A Bloise; A Tenore
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

2.  Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.

Authors:  M F Celani; G Giambuzzi; M Simoni; V Montanini
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

3.  TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.

Authors:  P Valensi; M E Combes; G Perret; J R Attali
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.